Literature DB >> 12154212

Immunization in rheumatic diseases of childhood: an audit of the clinical practice of British Paediatric Rheumatology Group members and a review of the evidence.

K Davies1, P Woo.   

Abstract

OBJECTIVES: To establish opinion and clinical practice of senior clinicians working with children with rheumatic diseases with regard to immunization and to determine whether or not this is in accordance with current recommendations. To review published guidelines on the subject and examine the evidence base supporting them.
METHODS: A questionnaire was sent to all consultant members of the British Paediatric Rheumatology Group. Information on a variety of issues relating to immunization practice in children with rheumatic diseases was collected. A review of published guidelines and the medical literature on the subject was undertaken to assess current recommendations for immunization in patients on immunosuppressive agents and the evidence supporting these.
RESULTS: A number of different sources of information are being used to decide whether or not to immunize patients with rheumatic diseases. Clinical practice varies between individuals. Areas of discordance include the doses of corticosteroids and disease-modifying drugs at which significant immunosuppression is felt likely to occur, the level of immunosuppression conferred by rheumatological diseases themselves and whether or not vaccination should be deferred in the presence of active disease. There was also variation in policy with regard to immunizations not part of the routine recommended schedule.
CONCLUSIONS: There is variation in both opinion and clinical practice regarding immunization in children with rheumatic diseases amongst senior clinicians working in the field of paediatric rheumatology. This reflects the lack of consistency between various sets of published guidelines and their non-specificity for rheumatic diseases and their treatment, and the lack of published evidence on the safety and efficacy of different vaccines in these situations. Further research is indicated in the hope that more specific guidelines may be developed for this not uncommonly encountered area of uncertainty.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12154212     DOI: 10.1093/rheumatology/41.8.937

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  11 in total

Review 1.  Should children under treatment for juvenile idiopathic arthritis receive flu vaccination?

Authors:  Liza J McCann
Journal:  Arch Dis Child       Date:  2007-04       Impact factor: 3.791

Review 2.  [Vaccination and multiple sclerosis].

Authors:  M Löbermann; A Winkelmann; E C Reisinger; U K Zettl
Journal:  Nervenarzt       Date:  2010-02       Impact factor: 1.214

Review 3.  Immunization of children with secondary immunodeficiency.

Authors:  Susanna Esposito; Elisabetta Prada; Mara Lelii; Luca Castellazzi
Journal:  Hum Vaccin Immunother       Date:  2015-07-15       Impact factor: 3.452

Review 4.  Vaccination in paediatric rheumatology.

Authors:  Jonathan D Akikusa; Nigel W Crawford
Journal:  Curr Rheumatol Rep       Date:  2014-08       Impact factor: 4.592

Review 5.  Vaccination in patients with immunosuppression.

Authors:  Ahmet Arvas
Journal:  Turk Pediatri Ars       Date:  2014-09-01

Review 6.  Vaccinations in juvenile chronic inflammatory diseases: an update.

Authors:  Clovis A Silva; Nadia E Aikawa; Eloisa Bonfa
Journal:  Nat Rev Rheumatol       Date:  2013-07-02       Impact factor: 20.543

7.  Immunization history of children with inflammatory bowel disease.

Authors:  Ing Shian Soon; Jennifer C C deBruyn; Iwona Wrobel
Journal:  Can J Gastroenterol       Date:  2013-04       Impact factor: 3.522

Review 8.  [Immunization in children and adolescents with rheumatic diseases].

Authors:  K Minden; M Niewerth; M Borte; W Singendonk; J-P Haas
Journal:  Z Rheumatol       Date:  2007-03       Impact factor: 1.372

9.  Hepatitis B vaccination in children with juvenile idiopathic arthritis.

Authors:  O Kasapçopur; F Cullu; A Kamburoğlu-Goksel; H Cam; E Akdenizli; S Calýkan; L Sever; N Arýsoy
Journal:  Ann Rheum Dis       Date:  2004-09       Impact factor: 19.103

Review 10.  Role of adalimumab in the management of children and adolescents with juvenile idiopathic arthritis and other rheumatic conditions.

Authors:  Katherine Anne B Marzan
Journal:  Adolesc Health Med Ther       Date:  2012-06-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.